Grants/Awards
Overview of grants and awards received by our research group during the last few years.
Main content
2024 | |
The Norwegian Cancer Society - Pioneer project Oleksii Nikolaienko, researcher at Mohn Cancer Research Laboratory, received funding from "The Norwegian Cancer Society Pioneer Projects" for the project: "Low-level epimutational mosaicism in tumour suppressor genes - a generic cancer risk factor".  Photo:
Kreftforeningen
| |
2023 | |
Award from SfE (Society for Endocrinology) - "Paper of the year" in Endocrine-Related Cancer (2023) Andreas Venizelos, former postdoc. at Mohn Cancer Research Laboratory, received an award for "Paper of the year" in the medical journal Endocrine-Related Cancer, on behalf of the co-authors, for the article: "The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms". The award was presented at the SfE BES in Glasgow on 15th November 2023.  Photo:
Mohn kreftforskningslaboratorium
| |
Nora D. Hatletvedt, enrolled in the Medical Student Research Programme at Mohn Cancer Research Laboratory, received a prize for "Best presentation" with her presentation: "MDM2 polymorphisms and bone marrow recovery in breast cancer patients during neoadjuvant chemotherapy".  Photo:
UiB
| |
Research School in Clinical Medicine at UiB - Prize for best poster Christina Engebrethsen, PhD student at Mohn Cancer Research Laboratory, received a prize for the 1st place in the category "Best poster" with her poster: "Homologous recombination deficiency in breast cancer".  Photo:
UiB
| |
2022 | |
The Norwegian Cancer Society - Pioneer project Wei Deng, researcher at Mohn Cancer Research Laboratory, received funding from "The Norwegian Cancer Society Pioneer Projects" for the project: "A new method for measuring cell division for more personalized cancer treatment". Photo:
Kreftforeningen
| |
Helse Vest - Open project support - "Epimutations in MGMT and MLH1 and risk of cancers of the colon, endometrium and glioblastomas" (Per Eystein Lønning). - "Predictive markers in Her2-positive breast cancer" (Stian Knappskog).  Photo:
Helse Vest
| |
Helse Vest - Open project support (extension) - "Identifying genomic alterations predicting response to neoadjuvant endocrine therapy" (Hans Petter Eikesdal). Photo:
Helse Vest
| |
Breast Cancer Association - Project grant from Pink Ribbon campaign - "Is BRCA1-methylation in early embryonic life the first step towards cancer?" (Stian Knappskog).  Photo:
Kreftforeningen
| |
Meltzer Research Fund - Project Scholarship Nigar Sofiyeva, MD, the final year PhD student at K.G. Jebsen Center for Genome-Directed Cancer Therapy and Mohn Cancer Research Laboratory at the University of Bergen, received the Meltzer Foundation Award 2022. The prize was awarded by The Meltzer Research Fund and is assigned to PhD. candidates and graduate students meeting “Meltzer quality” requirements as support for the academic project. Dr. Sofiyeva has received the maximum allocated amount of 75,000 NOK, and her research project aims to evaluate the regulatory mechanisms of driver genes in breast cancer.  Photo:
UiB/Mohn kreftforskningslaboratorium
| |
| 2021 | |
Kristian Gerhard Jebsen Foundation - Project grant (extension) Extension of project grant linked to the "K.G. Jebsen Center for Genome-Directed Cancer Therapy".  Photo:
Stiftelsen Kristian Gerhard Jebsen
| |
Personalized Breast Cancer Treatment (Pink Ribbon) - Research project - "Personalized treatment based on gene analysis of hormone-sensitive breast cancer" (Hans Petter Eikesdal). - "Immune-related mechanisms by anti-Her2 treatment" (Stian Knappskog). Photo:
Kreftforeningen
| |
Helse Vest - Open project support - "Identifying genomic alterations predicting response to neoadjuvant endocrine therapy" (Hans Petter Eikesdal). Photo:
Helse Vest
| |
| 2019 | |
Helse Vest - Open project support - "Normal Cell BRCA1 methylation and risk of Breast- and Ovarian Cancer" (Per Eystein Lønning). - "Molecular mechanisms dictating chemoresistance in patients with breast cancer" (Stian Knappskog). Photo:
Helse Vest
| |
Award from The Medical Faculty at UiB - "Research group of the year" The Breast Cancer Group led by Per Eystein Lønning, Clinical institute 2 (K2), received the award for "research group of the year" at the Medical Faculty. Jury reasoning: This years award for best research group goes to the Breast Cancer Group at K2, led by professor Per Eystein Lønning. The group has for many years produced high quality research and contributed to groundbreaking scientific findings in the breast cancer field. The group has also been running the Mohn Cancer Laboratory and published frequently in high impact journals like Cancer Cell, Plos genetics, Nature Medicine, as well as Annals of Internal Medicine. Good access to external financing has enabled to group to contribute to building up the good cancer research environment here at the faculty.  Photo:
Jørgen Barth - Per Eystein Lønning mottar prisen for årets forskningsgruppe.
| |
| 2018 | |
Helse Vest - Clinical research grant "Targeted therapy of triple negative breast cancer - from lab to patient care" (Hans Petter Eikesdal). Photo:
Helse Vest
| |
Kristian Gerhard Jebsen Foundation- Project grant The Breast Cancer Group, led by Per Eystein Lønning, received financial support from the foundation to establish the "K.G. Jebsen Center for Genome-Directed Cancer Therapy". The new center consists of researchers and clinicians from UiB and the Cancer Department at Haukeland University Hospital, in addition to pathologists and bioinformaticians from the Sanger Institute in Cambridge, England. Photo:
Stiftelsen Kristian Gerhard Jebsen
| |
The Norwegian Research Council - Free project support for medicine, health and biology (FRIMEDBIO) - "Genetic alterations governing response to breast cancer therapy" (Stian Knappskog). - "Prenatal BRCA1 methylation and breast and ovarian cancer risk" (Per Eystein Lønning).  Photo:
Forskningsrådet
|